Psoriatic arthritis

被引:0
作者
Claudepierre, P. [2 ]
Bagot, M. [1 ]
机构
[1] Hop Henri Mondor, Serv Dermatol, F-94010 Creteil, France
[2] Hop Henri Mondor, Serv Rhumatol, F-94010 Creteil, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2008年 / 135卷
关键词
psoriatic arthritis; spondylitis; methotrexate; leflunomide; TNF-alpha inhibitors;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriatic arthritis is a comorbidity frequently associated to psoriasis. A major problem is the absence of diagnostic criteria and the lack of consensus on the classification criteria of this arthritis. The clinical presentation is extremely variable, since axial, peripheric, and enthe-sopathic lesions can exist atone, successively or in association in a same patient. Peripheric lesions can be mono- or more often oligo- or polyarthritis. Onychopathies and dactylitis are frequently associated to arthritis. The dermatologist must recognize psoriatic arthritis at an early stage, in order to avoid the development of destructive Lesions. The treatment includes symptomatic treatments (antalgics, non steroidal anti-inflammatory agents, corticosteroids), long-term treatments (sulfasalazine, methotrexate, azathioprine, ciclosporine, leflunomide), and TNF-alpha-inhibitors. Therapeutic strategies must be adapted to the clinical presentation. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S263 / S268
页数:6
相关论文
共 14 条
[1]  
Bennett RM., 1979, ARTHRITIS RELATED CO, P645
[2]   Anti-TNF alpha in the treatment of psoriatic arthritis [J].
Claudepierre, P ;
Wendling, D ;
Cohen, JD .
PRESSE MEDICALE, 2006, 35 (04) :647-655
[3]   THE EUROPEAN-SPONDYLARTHROPATHY-STUDY-GROUP PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SPONDYLARTHROPATHY [J].
DOUGADOS, M ;
VANDERLINDEN, S ;
JUHLIN, R ;
HUITFELDT, B ;
AMOR, B ;
CALIN, A ;
CATS, A ;
DIJKMANS, B ;
OLIVIERI, I ;
PASERO, G ;
VEYS, E ;
ZEIDLER, H .
ARTHRITIS AND RHEUMATISM, 1991, 34 (10) :1218-1227
[4]  
Fournie B, 1999, Rev Rhum Engl Ed, V66, P446
[5]  
GLADMAN DD, 1987, Q J MED, V62, P127
[6]   Psoriatic arthritis: performance of rheumatologists in daily practice [J].
Gorter, S ;
van der Heijde, DMFM ;
van der Linden, S ;
Houben, H ;
Rethans, JJ ;
Scherpbier, AJJA ;
van der Vleuten, CPM .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (03) :219-224
[7]   Which second-line treatments are optimal in psoriatic arthritis? [J].
Goupille, P .
JOINT BONE SPINE, 2002, 69 (03) :244-248
[8]   Guideline for anti-TNF-α therapy in psoriatic arthritis [J].
Kyle, S ;
Chandler, D ;
Griffiths, CEM ;
Helliwell, P ;
Lewis, J ;
McInnes, I ;
Oliver, S ;
Symmons, D ;
McHugh, N .
RHEUMATOLOGY, 2005, 44 (03) :390-397
[9]  
McGonagle D, 1999, ARTHRITIS RHEUM, V42, P1080, DOI 10.1002/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO
[10]  
2-7